HLA antibody profiling in thoracic transplantation undergoing desensitization therapy

Area of Science:

• Immunology
• Transplantation Medicine
• Cardiology

Background:

• Allosensitization is a significant barrier to thoracic transplantation.
• Sensitized patients awaiting transplants have poorer outcomes.
• Advances in HLA antibody detection improve accuracy.

Purpose of the Study:

• To review the characterization of human leukocyte antigen (HLA) antibodies before and after desensitization therapies.
• To assess changes in HLA antibody titer and function to promote safer thoracic transplantation.
• To evaluate the risk of early antibody-mediated rejection (AMR).

Main Methods:

• Review of desensitization therapies for sensitized thoracic transplant candidates.
• Characterization of HLA antibodies using advanced solid-phase assays.
• Monitoring of antibody levels and function pre- and post-intervention.

Main Results:

• The proportion of sensitized adult and pediatric patients awaiting thoracic transplants is increasing.
• Elevated panel reactive antibodies correlate with poorer transplant outcomes.
• Monitoring HLA antibodies post-desensitization aids in assessing transplant safety and AMR risk.

Conclusions:

• Allosensitization remains a major challenge in thoracic transplantation.
• Efficacy of desensitization protocols can be determined by monitoring antibody profiles.
• Improved immunologic risk stratification increases transplantation likelihood and reduces AMR.